Baidu
map

感染指南

订阅

MedSci主页 / 所有栏目 / 感染指南

2016 带状疱疹后神经痛诊疗中国专家共识

2016-03-30 中国神经内科相关专家小组（统称） 中国疼痛医学杂志.2016,22(3):161-167.

带状疱疹

带状疱疹后神经痛 (postherpetic neuralgia, PHN)定义为带状疱疹 (Herpes Zoster, HZ) 皮疹愈合后持续1 个月及以上的疼痛，是带状疱疹最常见的并发症。PHN 是最常见的一种神经病理性疼痛，可表现为持续性疼痛，也可缓解一段时间后再次出现。

中文标题：

2016 带状疱疹后神经痛诊疗中国专家共识

发布机构：

中国神经内科相关专家小组（统称）

发布日期：

2016-03-30

简要介绍：

带状疱疹后神经痛 (postherpetic neuralgia, PHN)定义为带状疱疹 (Herpes Zoster, HZ) 皮疹愈合后持续1 个月及以上的疼痛，是带状疱疹最常见的并发症。PHN 是最常见的一种神经病理性疼痛，可表现为持续性疼痛，也可缓解一段时间后再次出现。

制定者：

中国神经内科相关专家小组（统称）
带状疱疹后神经痛诊疗共识编写专家组

拓展指南：与带状疱疹相关指南：

相关资料下载：
[AttachmentFileName(sort=100, fileName=2016 带状疱疹后神经痛诊疗中国专家共识)] GetToolGuiderByIdResponse(projectId=1, id=c54fc1c00126814a, title=2016 带状疱疹后神经痛诊疗中国专家共识, enTitle=, guiderFrom=中国疼痛医学杂志.2016,22(3):161-167., authorId=null, author=, summary=带状疱疹后神经痛 (postherpetic neuralgia, PHN)定义为带状疱疹 (Herpes Zoster, HZ) 皮疹愈合后持续1 个月及以上的疼痛，是带状疱疹最常见的并发症。PHN 是最常见的一种神经病理性疼痛，可表现为持续性疼痛，也可缓解一段时间后再次出现。, cover=, journalId=null, articlesId=null, associationId=724, associationName=中国神经内科相关专家小组（统称）, associationIntro=null, copyright=0, guiderPublishedTime=Wed Mar 30 00:00:00 CST 2016, originalUrl=, linkOutUrl=, content=带状疱疹后神经痛 (postherpetic neuralgia, PHN)定义为带状疱疹 (Herpes Zoster, HZ) 皮疹愈合后持续1 个月及以上的疼痛，是带状疱疹最常见的并发症。PHN 是最常见的一种神经病理性疼痛，可表现为持续性疼痛，也可缓解一段时间后再次出现。<br> <br> <span style="font-weight: bold;">制定者：</span> <div>中国神经内科相关专家小组（统称） <div>带状疱疹后神经痛诊疗共识编写专家组<br><br> 拓展指南：<strong>与<font color=red>带状疱疹</font>相关指南：</strong><br><ul><li><a href="//www.sandwebs.com/guideline/show_article.do?id=9a5371c0011a147d" title="2014 CPS共识声明：带状疱疹疫苗预防带状疱疹后遗神经痛的安全性和有效性（更新版）" target=_blank>2014 CPS共识声明：带状疱疹疫苗预防带状疱疹后遗神经痛的安全性和有效性（更新版）</a></li> <li><a href="//www.sandwebs.com/guideline/show_article.do?id=091f81c001032300" title="中国带状疱疹治疗指南（草稿）" target=_blank>中国带状疱疹治疗指南（草稿）</a></li> 更多信息请点击：<a href="//www.sandwebs.com/guideline/list.do?q=%E5%B8%A6%E7%8A%B6%E7%96%B1%E7%96%B9" target=_blank>有关带状疱疹更多指南</a></ul> </div></div>, tagList=[TagDto(tagId=6986, tagName=带状疱疹)], categoryList=[CategoryDto(categoryId=9, categoryName=感染, tenant=100), CategoryDto(categoryId=17, categoryName=神经科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=3, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=11077, appHits=1958, showAppHits=6, pcHits=7440, showPcHits=3063, likes=153, shares=145, comments=18, approvalStatus=1, publishedTime=Fri Sep 02 14:20:04 CST 2016, publishedTimeString=2016-03-30, pcVisible=1, appVisible=1, editorId=5295957, editor=lili, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=lili, createdTime=Fri Sep 02 14:20:04 CST 2016, updatedBy=null, updatedName=null, updatedTime=Fri Jan 05 17:19:17 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2016 带状疱疹后神经痛诊疗中国专家共识)])
2016 带状疱疹后神经痛诊疗中国专家共识
下载请点击：
评论区 (15)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2113982, encodeId=66de21139829f, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210225/938039c6a8dd44da88f12057ac560714/12320b429ac14066810455a5a10e4aa9.jpg, createdBy=4dea2051957, createdName=189****1979, createdTime=Fri Feb 10 16:13:47 CST 2023, time=2023-02-10, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2107701, encodeId=192b210e701cc, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7a42612167, createdName=125fb8b5m59暂无昵称, createdTime=Tue Dec 27 18:56:57 CST 2022, time=2022-12-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2107202, encodeId=0a62210e2020f, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7a42612167, createdName=125fb8b5m59暂无昵称, createdTime=Fri Dec 23 21:01:08 CST 2022, time=2022-12-23, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1010001, encodeId=a13b101000106, content=好！！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=20e12291340, createdName=121e853cm73暂无昵称, createdTime=Sat Aug 21 12:55:02 CST 2021, time=2021-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=955326, encodeId=b40095532694, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae8b5455393, createdName=ms9000001373853973, createdTime=Thu Apr 08 22:49:22 CST 2021, time=2021-04-08, status=1, ipAttribution=)]
    2023-02-10 189****1979 来自河北省

    感谢分享

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2113982, encodeId=66de21139829f, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210225/938039c6a8dd44da88f12057ac560714/12320b429ac14066810455a5a10e4aa9.jpg, createdBy=4dea2051957, createdName=189****1979, createdTime=Fri Feb 10 16:13:47 CST 2023, time=2023-02-10, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2107701, encodeId=192b210e701cc, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7a42612167, createdName=125fb8b5m59暂无昵称, createdTime=Tue Dec 27 18:56:57 CST 2022, time=2022-12-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2107202, encodeId=0a62210e2020f, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7a42612167, createdName=125fb8b5m59暂无昵称, createdTime=Fri Dec 23 21:01:08 CST 2022, time=2022-12-23, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1010001, encodeId=a13b101000106, content=好！！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=20e12291340, createdName=121e853cm73暂无昵称, createdTime=Sat Aug 21 12:55:02 CST 2021, time=2021-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=955326, encodeId=b40095532694, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae8b5455393, createdName=ms9000001373853973, createdTime=Thu Apr 08 22:49:22 CST 2021, time=2021-04-08, status=1, ipAttribution=)]
    2022-12-27 125fb8b5m59暂无昵称 来自江苏省

    感谢分享

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2113982, encodeId=66de21139829f, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210225/938039c6a8dd44da88f12057ac560714/12320b429ac14066810455a5a10e4aa9.jpg, createdBy=4dea2051957, createdName=189****1979, createdTime=Fri Feb 10 16:13:47 CST 2023, time=2023-02-10, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2107701, encodeId=192b210e701cc, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7a42612167, createdName=125fb8b5m59暂无昵称, createdTime=Tue Dec 27 18:56:57 CST 2022, time=2022-12-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2107202, encodeId=0a62210e2020f, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7a42612167, createdName=125fb8b5m59暂无昵称, createdTime=Fri Dec 23 21:01:08 CST 2022, time=2022-12-23, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1010001, encodeId=a13b101000106, content=好！！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=20e12291340, createdName=121e853cm73暂无昵称, createdTime=Sat Aug 21 12:55:02 CST 2021, time=2021-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=955326, encodeId=b40095532694, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae8b5455393, createdName=ms9000001373853973, createdTime=Thu Apr 08 22:49:22 CST 2021, time=2021-04-08, status=1, ipAttribution=)]
    2022-12-23 125fb8b5m59暂无昵称 来自江苏省

    学习了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2113982, encodeId=66de21139829f, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210225/938039c6a8dd44da88f12057ac560714/12320b429ac14066810455a5a10e4aa9.jpg, createdBy=4dea2051957, createdName=189****1979, createdTime=Fri Feb 10 16:13:47 CST 2023, time=2023-02-10, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2107701, encodeId=192b210e701cc, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7a42612167, createdName=125fb8b5m59暂无昵称, createdTime=Tue Dec 27 18:56:57 CST 2022, time=2022-12-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2107202, encodeId=0a62210e2020f, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7a42612167, createdName=125fb8b5m59暂无昵称, createdTime=Fri Dec 23 21:01:08 CST 2022, time=2022-12-23, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1010001, encodeId=a13b101000106, content=好！！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=20e12291340, createdName=121e853cm73暂无昵称, createdTime=Sat Aug 21 12:55:02 CST 2021, time=2021-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=955326, encodeId=b40095532694, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae8b5455393, createdName=ms9000001373853973, createdTime=Thu Apr 08 22:49:22 CST 2021, time=2021-04-08, status=1, ipAttribution=)]
    2021-08-21 121e853cm73暂无昵称

    好！！

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2113982, encodeId=66de21139829f, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210225/938039c6a8dd44da88f12057ac560714/12320b429ac14066810455a5a10e4aa9.jpg, createdBy=4dea2051957, createdName=189****1979, createdTime=Fri Feb 10 16:13:47 CST 2023, time=2023-02-10, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2107701, encodeId=192b210e701cc, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7a42612167, createdName=125fb8b5m59暂无昵称, createdTime=Tue Dec 27 18:56:57 CST 2022, time=2022-12-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2107202, encodeId=0a62210e2020f, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7a42612167, createdName=125fb8b5m59暂无昵称, createdTime=Fri Dec 23 21:01:08 CST 2022, time=2022-12-23, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1010001, encodeId=a13b101000106, content=好！！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=20e12291340, createdName=121e853cm73暂无昵称, createdTime=Sat Aug 21 12:55:02 CST 2021, time=2021-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=955326, encodeId=b40095532694, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae8b5455393, createdName=ms9000001373853973, createdTime=Thu Apr 08 22:49:22 CST 2021, time=2021-04-08, status=1, ipAttribution=)]
    2021-04-08 ms9000001373853973

    学习

    0

以上为热门评论，梅斯医学App还有更多内容

相关指南

2014 CPS共识声明：带状疱疹疫苗预防带状疱疹后遗神经痛的安全性和有效性（更新版）

加拿大疼痛学会(CPS,Canadian Pain Society) · 2015-01-20

Baidu
map
Baidu
map
Baidu
map